Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BLRX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Thursday for BioLineRx Ltd. stock after gaining 0.90%
(Updated on Mar 28, 2024)

Sell candidate since Mar 25, 2024 Loss -13.85% PDF

The BioLineRx Ltd. stock price gained 0.90% on the last trading day (Thursday, 28th Mar 2024), rising from $1.11 to $1.12. During the last trading day the stock fluctuated 2.73% from a day low at $1.10 to a day high of $1.13. The price has risen in 6 of the last 10 days but is still down by -5.08% for this period. Volume fell on the last day by -184 thousand shares and in total, 163 thousand shares were bought and sold for approximately $182.66 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -17.51% during the next 3 months and, with a 90% probability hold a price between $0.750 and $1.12 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BLRX Signals & Forecast

There are few to no technical positive signals at the moment. The BioLineRx Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.19 and $1.20. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 22, 2024, and so far it has fallen -18.84%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for BioLineRx Ltd. stock

BioLineRx Ltd. finds support from accumulated volume at $1.11 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0300 between high and low, or 2.73%. For the last week the stock has had daily average volatility of 11.03%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BLRX) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect BioLineRx Ltd. to open at $1.12, and during the day (based on 14 day Average True Range), to move between $1.02 and $1.22, which gives a possible trading interval of +/-$0.102 (+/-9.11%) up or down from last closing price. If BioLineRx Ltd. takes out the full calculated possible swing range there will be an estimated 18.21% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.11 (0.89%) than the resistance at $1.14 (1.79%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is BioLineRx Ltd. stock A Buy?

BioLineRx Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -6.204 Strong Sell Candidate Unchanged

Predicted Opening Price for BioLineRx Ltd. of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$1.12 ( 0.298%) $1.12

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BLRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.15 2.38 %
R2 1.14 1.36 %
R1 1.13 0.726 %
Current price: 1.12
Support S1 1.11 -1.32 %
S2 1.10 -1.95 %
S3 1.09 -2.98 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.22 8.76 %
R2 1.20 7.14 %
R1 1.14 1.79 %
Current price 1.12
Support S1 1.11 -0.89%
S2 1.11 -1.34%
S3 1.03 -8.04%

FAQ

What is the symbol for BioLineRx Ltd. Stock and on which exchange is it traded?
The symbol for BioLineRx Ltd. is BLRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BioLineRx Ltd. Stock?
BioLineRx Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy BioLineRx Ltd. Stock?
BioLineRx Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioLineRx Ltd. Stock.

What's the current price of BioLineRx Ltd. Stock?
As of the end of day on the 2024-03-28, the price of an BioLineRx Ltd. (BLRX) share was $1.12.

What is the 52-week high and low for BioLineRx Ltd. Stock?
The 52-week high for BioLineRx Ltd. Stock is $2.53 and the 52-week low is $0.81.

What is the market capitalization of BioLineRx Ltd. Stock?
As of the 2024-03-28, the market capitalization of BioLineRx Ltd. is 106.405M.

When is the next earnings date for BioLineRx Ltd.?
The upcoming earnings date for BioLineRx Ltd. is May 22, 2024.
Click to get the best stock tips daily for free!

About BioLineRx Ltd.

BioLineRx Ltd. BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in pat... BLRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT